Delayed COVID-19 Respiratory Failure in Patients with Lymphoma on Rituximab-based Chemoimmunotherapy.

Hoffmann, Marc S; Ganguly, Siddhartha

Hoffmann, Marc S; Ganguly, Siddhartha.

Hoffmann MS; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS. Electronic address: mhoffmann@kumc.edu.
Ganguly S; Division of Hematologic Malignancies and Cellular Therapeutics, University of Kansas Cancer Center, Kansas City, KS.

Clin Lymphoma Myeloma Leuk ; 21(6): e548-e550, 2021 Jun.

Article in English | MEDLINE | ID: covidwho-1103793

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; COVID-19/complications; Lymphoma, Large B-Cell, Diffuse/complications; Respiratory Insufficiency/etiology; Rituximab/therapeutic use; Aged; COVID-19/diagnosis; Female; Humans; Immunotherapy; Lymphoma, Large B-Cell, Diffuse/drug therapy; Male; Middle Aged; SARS-CoV-2/isolation & purification

Keywords

COVID-19; Chemotherapy; Rituximab

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / Antineoplastic Combined Chemotherapy Protocols / Lymphoma, Large B-Cell, Diffuse / Rituximab / COVID-19 Type of study: Case report / Diagnostic study Topics: Long Covid Limits: Aged / Female / Humans / Male / Middle aged Language: English Journal: Clin Lymphoma Myeloma Leuk Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google